Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

June 1966

Volume 132 Kanamycin: Appraisal after Eight Years of Clinical Applications

Pages 773–1090

    1. OPENING REMARKS (pages 773–775)

      Maxwell Finland

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb42993.x

  1. Part I. In Vitro Activity, Pharmacology & General Clinical Status

    1. Top of page
    2. Part I. In Vitro Activity, Pharmacology & General Clinical Status
    3. Part II. Use in Tuberculosis
    4. Part III. Toxicity in Adults
    5. Part IV: Status in Pediatrics
    6. Part V. Summary
    1. Discussion of the Paper (pages 794–795)

      James H. Lannon

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb42995.x

    2. DEVELOPMENT OF RESISTANCE TO KANAMYCIN (pages 796–799)

      Lewis J. Griffith

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb42996.x

    3. THE CHEMISTRY OF KANAMYCIN—RECENT DEVELOPMENTS (pages 800–804)

      Irving R. Hooper

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb42997.x

    4. ABSORPTION, DISTRIBUTION, EXCRETION AND FATE OF KANAMYCIN (pages 811–818)

      Calvin M. Kunin

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb42999.x

    5. STATUS OF KANAMYCIN IN THERAPY OF INFECTIONS (pages 819–823)

      Paul A. Bunn and Joseph S. Lunn

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43000.x

    6. STATUS OF KANAMYCIN IN THE TREATMENT OF SURGICAL INFECTIONS (pages 824–833)

      Alexander M. Rutenburg

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43001.x

    7. KANAMYCIN IN URINARY TRACT INFECTIONS (pages 834–841)

      Robert G. Petersdorf and Marvin Turck

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43002.x

    8. CLINICAL EXPERIENCES WITH KANAMYCIN IN SEPTICEMIA CAUSED BY GRAM-NEGATIVE ORGANISMS (pages 842–849)

      J. McC. Murdoch, J. A. Gray, A. M. Geddes and E. T. Wallace

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43003.x

    9. GENERAL DISCUSSION (pages 854–859)

      W. M. M. KIRBY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43005.x

    10. STUDIES OF ABSORPTION OF KANAMYCIN BY AEROSOLIZATION (pages 870–878)

      Marcel Bilodeau, Joseph C. Roy and Maurice Giroux

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43007.x

    11. EFFECT OF NEOMYCIN AND KANAMYCIN UPON INTESTINAL ABSORPTION (pages 879–887)

      W. W. Faloon, I. C. Paes, D. Woolfolk, H. Nankin, K. Wallace and E.N. Haro

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43008.x

    12. GENERAL DISCUSSION (pages 888–891)

      PAUL A. BUNN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43009.x

  2. Part II. Use in Tuberculosis

    1. Top of page
    2. Part I. In Vitro Activity, Pharmacology & General Clinical Status
    3. Part II. Use in Tuberculosis
    4. Part III. Toxicity in Adults
    5. Part IV: Status in Pediatrics
    6. Part V. Summary
    1. KANAMYCIN: ITS THERAPEUTIC RECORD IN PULMONARY TUBERCULOSIS (pages 905–911)

      Osamu Kitamoto

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43012.x

    2. PANEL DISCUSSION (pages 926–931)

      SOL KATZ

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43014.x

  3. Part III. Toxicity in Adults

    1. Top of page
    2. Part I. In Vitro Activity, Pharmacology & General Clinical Status
    3. Part II. Use in Tuberculosis
    4. Part III. Toxicity in Adults
    5. Part IV: Status in Pediatrics
    6. Part V. Summary
    1. INTRODUCTORY REMARKS (page 932)

      William L. Hewitt

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43015.x

    1. KANAMYCIN IN THE TREATMENT OF PATIENTS WITH DIMINISHED KIDNEY FUNCTION (pages 933–940)

      Edwin M. Ory, Temple W. Williams Jr., Frederick A. Camp, Rolland F. Regester and Robert O. Morgen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43016.x

    2. Discussion of the Paper (page 941)

      Calvin Kunin

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43017.x

    3. TOXICITY OF KANAMYCIN IN ADULTS (pages 942–956)

      Sydney M. Finegold

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43018.x

    4. KANAMYCIN TOXICITY IN ADULTS (pages 957–967)

      Boris Kreis

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43019.x

    5. PANEL DISCUSSION: TOXICITY OF KANAMYCIN IN ADULTS (pages 968–983)

      S. M. FINEGOLD

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43020.x

  4. Part IV: Status in Pediatrics

    1. Top of page
    2. Part I. In Vitro Activity, Pharmacology & General Clinical Status
    3. Part II. Use in Tuberculosis
    4. Part III. Toxicity in Adults
    5. Part IV: Status in Pediatrics
    6. Part V. Summary
    1. STAPHYLOCOCCAL INFECTIONS IN NURSERIES (pages 992–998)

      Sydney Ross

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43022.x

    2. Discussion of the Paper (page 999)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43023.x

    3. STAPHYLOCOCCAL INFECTIONS IN NURSERIES (pages 1000–1005)

      James M. Sutherland and Irwin J. Light

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43024.x

    4. CLINICAL PHARMACOLOGY OF KANAMYCIN IN PREMATURE INFANTS (pages 1020–1025)

      Harold J. Simon and Stanton G. Axline

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43028.x

    5. EFFECTIVENESS OF KANAMYCIN IN MANAGEMENT OF GRAM-NEGATIVE SEPTICEMIA IN CHILDREN WITH MALIGNANT DISEASE (pages 1026–1027)

      William G. Thurman and M. H. Donaldson

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1966.tb43029.x

  5. Part V. Summary

    1. Top of page
    2. Part I. In Vitro Activity, Pharmacology & General Clinical Status
    3. Part II. Use in Tuberculosis
    4. Part III. Toxicity in Adults
    5. Part IV: Status in Pediatrics
    6. Part V. Summary

SEARCH

SEARCH BY CITATION